Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuanbiao Guo
Observed name:
Guo YuanBiao
Institutions:
Third People's Hospital of Chengdu,
Southwest Jiaotong University
Observed institutions:
Affiliated Hospital of Southwest Medical University,
Third People's Hospital of Chengdu,
Southwest Jiaotong University,
Chongqing Medical University
ORCID:
0000-0002-7571-8864
Observed ORCID:
0000-0002-7571-8864
OpenAlex ID:
A5028062929
Current strategies for improving limitations of proteolysis targeting chimeras
2022
·
Chunlan Pu
, Shirui Wang
, et al.
·
Chinese Chemical Letters
·
32
Enhancing therapeutic efficacy in homologous recombination-proficient pancreatic cancer via the combination of PARP1-PROTAC and a BRD4 inhibitor
2024
·
Chunlan Pu
, Yuanyuan Liu
, et al.
·
Bioorganic & Medicinal Chemistry
·
8
PDF
Research progress of BRD4 in head and neck squamous cell carcinoma: Therapeutic application of novel strategies and mechanisms
2024
·
Jiao Tang
, Huaqiu Chen
, et al.
·
Bioorganic & Medicinal Chemistry
·
5
PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage
2026
·
Qianyuan Gong
, Jianyu Liu
, et al.
·
Biochemical Pharmacology
Extracellular Vesicles: A Mailcoach From Mast Cell to Other Cell Species
2026
·
Bingqi Zhang
, Yueshan Sun
, et al.
·
Immunity Inflammation and Disease
Nontypeable Haemophilus influenzae isolates from the lower respiratory tract in Western Sichuan, China: MIC value of ofloxacin and Mutation characteristics of Quinolones Resistance determining region gene
2020
·
Wang Xiaolei
, Xie Jiang
, et al.
PDF
Show more works
View as search
Works count:
6
Citation count:
46
H-index:
3
I10-index:
1
Year
Topic
Type